BLACK DIAMOND THERAPEUTICS I's ticker is BDTX and the CUSIP is 09203E105. A total of 68 filers reported holding BLACK DIAMOND THERAPEUTICS I in Q3 2022. The put-call ratio across all filers is 0.96 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $544,000 | +1500.0% | 321,602 | +2501.3% | 0.00% | – |
| Q1 2022 | $34,000 | -54.1% | 12,363 | -10.6% | 0.00% | – |
| Q4 2021 | $74,000 | -64.9% | 13,825 | -44.6% | 0.00% | – |
| Q3 2021 | $211,000 | -85.2% | 24,963 | -78.6% | 0.00% | -100.0% |
| Q2 2021 | $1,424,000 | +371.5% | 116,845 | +837.4% | 0.00% | – |
| Q1 2021 | $302,000 | -30.6% | 12,465 | -8.1% | 0.00% | – |
| Q4 2020 | $435,000 | +45.0% | 13,560 | +36.7% | 0.00% | – |
| Q3 2020 | $300,000 | -54.6% | 9,923 | -36.7% | 0.00% | -100.0% |
| Q2 2020 | $661,000 | +94.4% | 15,670 | +15.0% | 0.00% | – |
| Q1 2020 | $340,000 | – | 13,625 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| NEA Management Company, LLC | 3,449,845 | $86,074,000 | 4.50% |
| Boxer Capital, LLC | 2,014,858 | $50,271,000 | 3.43% |
| RA Capital Management | 2,589,904 | $64,618,000 | 2.04% |
| Artal Group S.A. | 1,696,517 | $42,328,000 | 1.79% |
| Logos Global Management LP | 123,465 | $2,772,000 | 1.05% |
| BVF INC/IL | 378,788 | $9,451,000 | 0.88% |
| Casdin Capital, LLC | 289,395 | $7,220,000 | 0.77% |
| Perceptive Advisors | 1,104,656 | $27,561,000 | 0.72% |
| Bellevue Group AG | 1,330,000 | $33,184,000 | 0.64% |
| Vivo Capital, LLC | 252,119 | $6,290,000 | 0.57% |